Kessler: New Lorillard Products Stalled
CEO says company's portfolio expansion "temporarily slowed down" by FDA
UBS-CSP Report, Part III: Newport's 1%
That's the market share most c-store operators predict for Lorillard's nonmenthol cigarette this year